Olmsted Syndrome
Author(s) -
Renata Elise Tonoli,
Damiê De Villa,
Renata Hübner Frainer,
Luana Pizzarro Meneghello,
Nelson Ricachnevsky,
Maurício de Quadros
Publication year - 2012
Publication title -
case reports in dermatological medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6471
pISSN - 2090-6463
DOI - 10.1155/2012/927305
Subject(s) - medicine , keratoderma , palmoplantar keratoderma , dermatology , rare disease , pediatrics , disease , surgery , hyperkeratosis , pathology
Olmsted syndrome is a rare congenital, sharply circumscribed transgredient palmoplantar keratoderma. It was first described by Olmsted in 1927. The diagnosis of this rare disease depends on clinical features like symmetrical involvement of keratoderma of the palms and soles and the symmetrical hyperkeratotic plaques around the body orifices. It starts in the neonatal period or in childhood. The disease has a slow but progressive and extremely disabling course. Treatment of Olmsted syndrome is often based on topical therapy with retinoic acid, corticosteroid, emollients, and keratolytics. The present paper describes a case of Olmsted syndrome and its treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom